-transparent.png){kind=logo}
We have examined several aspects of protein tyrosine kinase (PTK)-activity in the cytosolic and membrane fractions of both normal and malignant lymphoid cells. The expression of the PTK-encoding oncogenes fes, abl and src, was investigated with the use of antibodies generated to their respective gene products. These antibodies recognized proteins in all cell types examined, most frequently in both the cytosolic and the membrane fraction. PTKs were partially characterized by FPLC. PTK-activities of column fractions were assayed using a non-radioactive dot blot assay. Cytosolic and membrane fractions showed FPLC patterns with a constant as well as a variable part in both normal and malignant cells, suggestive of PTKs with specialized functions in normal cell growth and transformation. Lastly, using antibodies to phosphotyrosine, we found that cytosolic fractions contained the majority of proteins phosphorylated at tyrosine in all cell types. Normal peripheral blood lymphocytes and B-lymphoma cells showed a great similarity in tyrosine phosphorylation pattern, while in tonsillar lymphocytes a clearly different pattern was found. These methods further characterize PTK-activities in lymphoid cells, and the results give evidence that PTKs in normal and malignant cells have both similar and different aspects.
C J Punt, and
G Rijksen, and
B A van Oirschot, and
G P Kester-Schipper, and
M C van der Heijden, and
A W Dekker, and
G E Staal
June 1986,
Archives of biochemistry and biophysics,
C J Punt, and
G Rijksen, and
B A van Oirschot, and
G P Kester-Schipper, and
M C van der Heijden, and
A W Dekker, and
G E Staal
August 1979,
Cell differentiation,
C J Punt, and
G Rijksen, and
B A van Oirschot, and
G P Kester-Schipper, and
M C van der Heijden, and
A W Dekker, and
G E Staal
January 1985,
Leukemia research,
C J Punt, and
G Rijksen, and
B A van Oirschot, and
G P Kester-Schipper, and
M C van der Heijden, and
A W Dekker, and
G E Staal
September 1985,
FEBS letters,
C J Punt, and
G Rijksen, and
B A van Oirschot, and
G P Kester-Schipper, and
M C van der Heijden, and
A W Dekker, and
G E Staal
August 1997,
Carcinogenesis,
C J Punt, and
G Rijksen, and
B A van Oirschot, and
G P Kester-Schipper, and
M C van der Heijden, and
A W Dekker, and
G E Staal
January 1987,
Annals of the New York Academy of Sciences,
C J Punt, and
G Rijksen, and
B A van Oirschot, and
G P Kester-Schipper, and
M C van der Heijden, and
A W Dekker, and
G E Staal
February 1992,
Journal of neurochemistry,
C J Punt, and
G Rijksen, and
B A van Oirschot, and
G P Kester-Schipper, and
M C van der Heijden, and
A W Dekker, and
G E Staal
May 1985,
FEBS letters,
C J Punt, and
G Rijksen, and
B A van Oirschot, and
G P Kester-Schipper, and
M C van der Heijden, and
A W Dekker, and
G E Staal
January 1984,
Advances in cyclic nucleotide and protein phosphorylation research,
C J Punt, and
G Rijksen, and
B A van Oirschot, and
G P Kester-Schipper, and
M C van der Heijden, and
A W Dekker, and
G E Staal
January 1985,
Annual review of biochemistry,
